Genetically engineered mouse models providing a tissue-wide ‘first hit’ of Apc either in the germline or somatically and requiring only a further single sporadic mutation of the wild-type allele for tumour initiation provide a simple and immediate route to clonal tumorigenesis. This evidence concerns the gene APC and neoplasm.